Trial record 1 of 9 for:    Immunovative
Previous Study | Return to List | Next Study

Study of AlloStim In-Situ Vaccine in Pre-Treated Metastatic Breast Cancer

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified November 2013 by Immunovative Therapies, Ltd.
Sponsor:
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.
ClinicalTrials.gov Identifier:
NCT01741038
First received: November 29, 2012
Last updated: November 21, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)